Angiogenesis defects and mesenchymal apoptosis in mice lacking SMAD5

Development

Volumn 126, Issue 8, 1999, Pages 1571-1580

  Yang, Xiao ^a   Castilla, Lucio H ^b   Xu, Xiaoling ^a   Li, Cuiling ^a   Gotay, Jessica ^a   Weinstein, Michael ^a   Liu, Pu Paul ^b   Deng, Chu Xia ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Angiogenesis; Apoptosis; Gene targeting; Mouse; SMAD5; Vasculogenesis; Yolk sac

Indexed keywords

BONE MORPHOGENETIC PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; EMBRYO; EMBRYO DEVELOPMENT; ERYTHROID PRECURSOR CELL; GENE MUTATION; GENE TARGETING; GENETIC RECOMBINATION; HOMOZYGOTE; MESENCHYME; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER; SOMITE; VASCULAR SMOOTH MUSCLE; YOLK SAC;

ANIMALS; APOPTOSIS; DNA-BINDING PROTEINS; ERYTHROID PROGENITOR CELLS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GENE TARGETING; HEMATOPOIETIC STEM CELLS; MESODERM; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PHOSPHOPROTEINS; SMAD5 PROTEIN; TRANS-ACTIVATORS; YOLK SAC;

ANIMALIA; VERTEBRATA;

EID: 0032960886     PISSN: 09501991     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Abdollah, S., Macias-Silva, M., Tsukazaki, T., Hayashi, H., Attisano, L. and Wrana, J. L. (1997). TGF-betaRI phosphorylation of Smad2 on Ser465 and Ser467 is required for Smad2-Smad4 complex formation and signaling. J. Biol. Chem. 272, 27678-27685.
2. Akhurst, R. J., Lehnert, S. A., Faissner, A. and Duffie, E. (1990). TGF beta in murine morphogenetic processes: the early embryo and cardiogenesis. Development 108, 645-656.
3. Baker, J. C. and Harland, R. M. (1996). A novel mesoderm inducer, Madr2, functions in the activin signal transduction pathway. Genes Der. 10, 1880-1889.
4. Beck, L., Jr. and D'Amore, P. A. (1997). Vascular development: cellular and molecular regulation. FASEB J. 11, 365-373.
5. Bruno, E., Horrigan, S. K., Van Den Berg, D., Rozler, E., Fitting, P. R., Moss, S. T., Westbrook, C. and Hoffman, R. (1998). The Smad5 gene is involved in the intracellular signaling pathways that mediate the inhibitory effects of transforming growth factor-beta on human hematopoiesis. Blood 91, 1917-1923.
6. Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., Declercq, C., Pawling, J., Moons, L., Collen, D., Risau, W. and Nagy, A. (1996). Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439.
7. Deng, C., Wynshaw-boris, A., Shen, M. M., Daugherty, C., Ornitz, D. M. and Leder, P. (1994). Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev. 8, 3045-3057.
8. Deng, C., Wynshaw-Boris, A., Zhou, F., Kuo, A. and Leder, P. (1996). Fibroblast growth factor receptor 3 is a negative regulator of bone growth. Cell 84, 911-921.
9. Dickson, M. C., Martin, J. S., Cousins, F. M., Kulkarni, A. B., Karlsson, S. and Akhurst, R. J. (1995). Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 121, 1845-1854.
10. Dumont, D. J., Gradwohl, G., Fong, G. H., Puri, M. C., Gertsenstein, M., Auerbach, A. and Breitman, M. L. (1994). Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo. Genes Dev. 8, 1897-1907.
11. Evans, R., Kamdar, S. J., Fuller, J. A. and Krupke, D. M. (1995). The potential role of the macrophage colony-stimulating factor, CSF-1, in inflammatory responses: characterization of macrophage cytokine gene expression. J. Leuk. Biol. 58, 99-107.
12. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K., Powell-Braxton, L., Hillan, K. J. and Moore, M. W. (1996). Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442.
13. Flamme, I. and Risau, W. (1992). Induction of vasculogenesis and hematopoiesis in vitro. Development 116, 435-9.
14. Folkman, J. and D'Amore, P. A. (1996). Blood vessel formation: what is its molecular basis? [comment]. Cell 87, 1153-5.
15. Fong, G. H., Rossant, J., Gertsenstein, M. and Breitman, M. L. (1995). Role of the flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 376, 66-67.
16. Graff, J. M., Bansal, A. and Melton, D. A. (1996). Xenopus Mad proteins transduce distinct subsets of signals for the TGF beta superfamily. Cell 85, 479-487.
17. Hejlik, D. P., Kottickal, L. V., Liang, H., Fairman, J., Davis, T., Janecki, T., Sexton, D., Perry, W. r., Tavtigian, S. V., Teng, D. H. and Nagarajan, L. (1997). Localization of SMAD5 and its evaluation as a candidate myeloid tumor suppressor. Cancer Res. 57, 3779-3783.
18. Heldin, C. H., Miyazono, K. and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
19. Kawabata, M., Imamura, T. and Miyazono, K. (1998). Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev. 9, 49-61.
20. Kingsley, D. M. (1994). The TGF-beta superfamily: new members, new receptors and new genetic tests of function in different organisms. Genes Dev. 8, 133-146.
21. Kretzschmar, M., Liu, F., Hata, A., Doody, J. and Massague, J. (1997). The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase. Genes Dev. 11, 984-995.
22. Lagna, G., Hata, A., Hemmati-Brivanlou, A. and Massague, J. (1996). Partnership between DPC4 and SMAD proteins in TGF-beta signalling pathways. Nature 383, 832-836.
23. Lawler, S., Candia, A. F., Ebner, R., Shum, L., Lopez, A. R., Moses, H. L., Wright, C. V. E. and Derynck, R. (1994). The murine type II TGF-β receptor has a coincident embryonic expression and binding prefernce for TGF-β1. Development 120, 165-175.
24. Leveen, P., Pekny, M., Gebre-Medhin, S., Swolin, B., Larsson, E. and Betsholtz, C. (1994). Mice deficient for PDGF B show renal, cardiovascular and hematological abnormalities. Genes Dev 8, 1875-1887.
25. Lo, R. S., Chen, Y. G., Shi, Y., Pavletich, N. P. and Massague, J. (1998). The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-beta receptors. EMBO J. 17, 996-1005.
26. Macias-Silva, M., Abdollah, S., Hoodless, P. A., Pirone, R., Attisano, L. and Wrana, J. L. (1996). MADR2 is a substrate of the TGFbeta receptor and its phosphorylation is required for nuclear accumulation and signaling. Cell 87, 1215-1224.
27. Massague, J. (1998). TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791.
28. Nomura, M. and Li, E. (1998). Roles for Smad2 in mesoderm formation, left right patterning and craniofacial development in mice. Nature 393, 786-789.
29. Oshima, M., Oshima, H. and Taketo, M. M. (1996). TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev. Biol. 179, 297-302.
30. Pepper, M. S. (1997). Transforming growth factor-beta: vasculogenesis, angiogenesis and vessel wall integrity. Cytokine Growth Factor Rev. 8, 21-43.
31. Riggins, G. J., Thiagalingam, S., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Willson, J. K., Markowitz, S. D., Kinzler, K. W. and Vogelstein, B. (1996). Mad-related genes in the human. Nature Genet. 13, 347-349.
32. Risau, W. (1997). Mechanisms of angiogenesis. Nature 386, 671-4.
33. Roberts, A. B. and Sporn, M. B. (1990). The transforming growth factoes-beta. In Handbook of Experimental Pharmacology, Peptide Growth Factors and Their Receptors (ed. M. B. Sporn and A. B. Roberts), pp. 418-472. Heidelberg: Springer-Verlag.
34. Sato, T. N., Tozawa, Y., Deutsch, U., Wolburg-Buchholz, K., Fujiwara, Y., Gendron-Maguire, M., Gridley, T., Wolburg, H., Risau, W. and Qin, Y. (1995). Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 376, 70-74.
35. Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X. F., Breitman, M. L. and Schuh, A. C. (1995). Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66.
36. Sirard, C., de la Pompa, J. L., Elia, A., Itie, A., Mirtsos, C., Cheung, A., Hahn, S., Wakeham, A., Schwartz, L., Kern, S. E., Rossant, J. and Mak, T. W. (1998). The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. Genes Dev. 12, 107-119.
37. Soriano, P. (1994). Abnormal kidney development and hematological disorders in PDGF B-receptor mutant mice. Genes Dev. 8, 1888-1896.
38. Souchelnytskyi, S., Tamaki, K., Engstrom, U., Wernstedt, C., ten Dijke, P. and Heldin, C. H. (1997). Phosphorylation of Ser465 and Ser467 in the C terminus of Smad2 mediates interaction with Smad4 and is required for transforming growth factor-beta signaling. J. Biol. Chem. 272, 28107-28115.
39. Suri, C., Jones, P. F., Patan, S., Bartunkova, S., Maisonpierre, P. C., Davis, S., Sato, T. N. and Yancopoulos, G. D. (1996). Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell 87, 1171-1180.
40. Suzuki, A., Chang, C., Yingling, J. M., Wang, X. F. and Hemmati-Brivanlou, A. (1997). Smad5 induces ventral fates in Xenopus embryo. Dev Biol 184, 402-405.
41. Vu, T. H., Shipley, J. M., Bergers, G., Berger, J. E., Helms, J. A., Hanahan, D., Shapiro, S. D., Senior, R. M. and Werb, Z. (1998). MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93, 411-422.
42. Waldrip, W. R., Bikoff, E. K., Hoodless, P. A., Wrana, J. L. and Robertson, E. J. (1998). Smad2 signaling in extraembryonic tissues determines anterior-posterior polarity of the early mouse embryo. Cell 92, 797-808.
43. Wang, H. U., Chen, Z. and Anderson, D. J. (1998). Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell 93, 741-753.
44. Watanabe, T. K., Suzuki, M., Omori, Y., Hishigaki, H., Horie, M., Kanemoto, N., Fujiwara, T., Nakamura, Y. and Yakahashi, E. (1997). Cloning and characterization of a novel member of the human Mad gene family (MADH6). Gemonics 42, 446-451.
45. Weinstein, M., Yang, X., Li, C., Xu, X., Gotay, J. and Deng, C. (1998). Failure of egg cylinder elongation and mesoderm induction in mouse embryos lacking the tumor suppressor smad2. Proc. Natl. Acad. Sci. USA 95, 9378-9383.
46. Yang, X., Cuiling, L., Xiaoling, X. and Deng, C. X. (1998). The tumor suppressor SMAD4/DPC4 is essential for epiblast proliferation and mesoderm induction in mice. Proc. Natl. Acad. Sci. USA 95, 3667-3672.
47. Yang, X., Letterio, J. J., Lechleider, R. J., Chen, C., Hayman, R., Gu, H., Roberts, A. B. and Deng, C. X. (1999). Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-β. EMBO J. (in press).
48. Yingling, J. M., Das, P., Savage, C., Zhang, M., Padgett, R. W. and Wang, X. F. (1996). Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth. Proc. Natl. Acad. Sci. USA 93, 8940-8944.
49. Zavadil, J., Brezinova, J., Svoboda, P., Zemanova, Z. and Michalova, K. (1997). Smad5, a tumor suppressor candidate at 5q31.1, is hemizygously lost and not mutated in the retained allele in human leukemia cell line HL60. Leukemia 11, 1187-1192.
50. Zhang, Y., Feng, X., We, R. and Derynck, R. (1996). Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383, 168-172.
51. Zhu, Y., Richardson, J. A., Parada, L. F. and Graff, J. M. (1998). Smad3 mutant mice develop metastatic colorectal cancer. Cell 94, 703-714.